Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin treatment for idiopathic toe walking in children – randomized controlled assessor-blinded study
2009-017308-10Phase 4Completed
- Sponsor
- Heli Sätilä
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of neuronox in idiopathic toe walking (ITW) (2 arms), sponsored by Heli Sätilä. Primary endpoint: Long-term gait outcome at 2 years. Started Nov 2009; status: completed.
02
Drugs
neuronox
03
Conditions
idiopathic toe walking (ITW)
Beyond the preview
Go deeper on 2009-017308-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017308-10.